INmune Bio Inc
INmune Bio Inc (INMB) Option Chain
As of September 23, 2026, INmune Bio Inc is trading at $2.00, a +0.00% change from the previous close. The nearest expiration is Oct 16, 2026. Implied volatility is 59.5%. IV Rank is 2%.
Read more
Tracking the INMB option chain helps you see every strike and expiry on INmune Bio Inc in one view, so you can quickly identify the contracts that fit your thesis and your risk. INmune Bio Inc's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of INMB options activity at a glance. Use our scanner to monitor the INMB option chain in real time and filter for the INMB options trades that actually meet your criteria.
An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For INMB stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the INMB option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where INMB stock options are being actively traded and where they are not.
INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on treating women with relapse refractory ovarian carcinoma and patients with high-risk myelodysplastic syndrome; INB03, an immunotherapy that treats patients with hematologic malignancies and solid tumors; and XPro1595 for the treatment of Alzheimer's disease.
The company has license agreements with Xencor, Inc.; Immune Ventures, LLC; University of Pittsburg; and University College London. INmune Bio, Inc. was incorporated in 2015 and is headquartered in Boca Raton, Florida.
Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls INmune Bio Inc's full chain across every expiry, highlights the most liquid strikes, and lets you screen INMB options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of INMB stock options — let the full option chain come to you, pre-filtered and ready to trade.
Stock Statistics
- IndustryBiotechnology
- SectorHealthcare
- IV percentile1.59% Subdued
- Market cap (M$)56
- 52 weeks high-23.08%
- 52 weeks low83.49%
- Analyst recommendationStrong Buy
1.00 - Target price$7.00
250.00% above the current stock price - Dividend—
- Payout ratio—
- Earnings date2026-10-29
- P/E—
- Future P/E—
- EPS (ttm)-0.69
- EPS growth next 5 years25.15%
As of September 23, 2026
| CALLs | PUTs | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Prob. OTM % | Open Interest | Volume | Extrinsic Value | Intrinsic Value | Bid | Ask | Strike | Moneyness % | Bid | Ask | Intrinsic Value | Extrinsic Value | Volume | Open Interest | Prob. OTM % |
| 0.05 | 1 | 0 | 0.25 | 1.00 | 0.75 | 1.75 | 1.00 | -53.70 | — | 0.25 | 0.00 | 0.25 | 0 | 0 | 99.95 |
| 40.55 | 138 | 3 | 0.28 | 0.00 | 0.05 | 0.50 | 2.00 | -7.41 | — | 0.25 | 0.00 | 0.25 | 0 | 0 | 59.45 |
| 94.01 | 40 | 0 | 0.05 | 0.00 | — | 0.05 | 3.00 | +38.89 | 0.35 | 1.30 | 1.00 | -0.18 | 0 | 0 | 5.99 |
| 99.77 | 0 | 0 | 0.75 | 0.00 | — | 0.75 | 4.00 | +85.19 | 1.30 | 2.25 | 2.00 | -0.23 | 0 | 0 | 0.23 |
| 99.99 | 0 | 0 | 0.15 | 0.00 | — | 0.15 | 5.00 | +131.48 | 2.30 | 3.30 | 3.00 | -0.20 | 0 | 0 | 0.01 |
As of September 23, 2026
Scan the full option chain in one place
Browse the full INMB option chain across every strike and expiration, filter by IV, volume, and open interest, and evaluate your trade without switching tools.
Start your 14-day free trial→